A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

She led a two-day program in collaboration with Biotech TV and the NYSE, featuring an IPO Bootcamp with notable industry ...

Ray Dalio’s firm cuts 20% of its Microsoft stock holding, signaling a shift in tech focus. Cathie Wood’s Ark Invest also ...

Bank of America sees strong M&A potential in banking and biotech, with financials historically more active under Republicans.

Bluebird reports 17 people with sickle cell disease started receiving Lyfgenia gene therapy, with 35 starting Zynteglo for ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Monthly 140 mg erenumab injections are a safe and effective treatment for patients with nonopioid chronic migraine and medication overuse headaches.

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

According to a recent article in Biospace ,"The solid tumors market size reached a value of US$ 170.3 Billion in 2023. Looking forward, the market is expected to reach US$ 375.4 Billion by 2034, ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

John Feldman is taking over the reins from founder Michael Feldman of Feldman Deli’s, a Kosher-style deli in Salt Lake City, ...

The Biotechnology Innovation Organization (BIO) has commended a recent update from the USDA's Animal and Plant Health Inspection Service (APHIS), which has expanded exemptions for genetically modified ...